Streetbeat News

Regulatory

GLMD

Galmed Pharmaceuticals received a letter from Nasdaq on March 19, granting the company an additional 180 days to regain compliance, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 9:01 pm

TYRA

Tyra Biosciences Inc has filed with the SEC for the resale of up to 15.4 million shares by the selling securityholders. This move could potentially impact the stock's liquidity and market perception.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 9:00 pm

STLA

California Governor Newsom announced an agreement with Stellantis on vehicle emissions, where Stellantis agrees not to oppose California's authority under the Clean Air Act for its greenhouse gas and zero-emission standards.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 8:45 pm

CRNX

Crinetics Pharmaceuticals Inc has filed with the SEC for the resale of up to 8.33 million shares by the selling stockholders. This move could potentially increase the stock's liquidity but may also dilute current shareholders' value.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 8:43 pm

CRGY

Crescent Energy Company (CRGY) announced the pricing of a $700M private placement of 7.625% Senior Notes due 2032, to close on March 26, 2024. The proceeds, along with additional borrowings, will fund the purchase and potential full redemption of its outstanding 7.250% Senior Notes due 2026. The offering aims at qualified institutional buyers and non-US persons, under specific regulations.

Portfolio Pulse from Happy Mohamed

March 19, 2024 | 8:42 pm

CXW

GEO

The U.S. Supreme Court upheld Texas' border enforcement law, SB 4, allowing state and local law enforcement to arrest individuals suspected of illegal border crossings. This decision has sparked significant debate and criticism, particularly concerning federal immigration control and constitutional principles. Following the ruling, prison stocks CoreCivic Inc. (CXW) and Geo Group Inc. (GEO) saw a temporary increase in their stock prices.

Portfolio Pulse from Piero Cingari

March 19, 2024 | 8:40 pm

BTBT

Bit Digital has filed FormRW with the SEC, requesting the withdrawal of its previously filed registration statement on Form F-3 from February 1, 2022. This withdrawal affects an aggregate of 20,010,813 shares that were under the registration.

Portfolio Pulse from Happy Mohamed

March 19, 2024 | 8:39 pm

CJJD

China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) has regained compliance with the Nasdaq minimum bid price requirement after its stock price remained at or above $1.00 for 10 consecutive business days. This follows a 1-for-20 reverse stock split effective March 1, 2024, which was part of the company's efforts to meet Nasdaq's listing standards after initially failing to maintain the minimum bid price in June 2023.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 8:12 pm

PGEN

Precigen announced significant progress in the development of PRGN-2012 AdenoVerse immunotherapy for RRP treatment, planning a BLA submission for accelerated approval in 2H 2024. The company received FDA's Breakthrough Therapy Designation for PRGN-2012 and is advancing other studies, including PRGN-2009 in combination with pembrolizumab for cervical cancer, and PRGN-3006 and PRGN-3007 UltraCAR-T therapies. Financially, Precigen reported $62.9 million in cash and investments as of December 31, 2023, and a 16% reduction in SG&A costs year-over-year.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 8:11 pm

NYXH

Nyxoah announced that its DREAM US pivotal study met its primary endpoints. CEO Olivier Taelman stated they are finalizing the PMA application's fourth module and anticipate launching Genio in the U.S, pending FDA approval.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 8:06 pm